The EU advises not to approve lecanemab, a controversial drug for Alzheimer's.

Media contributions

• Title	The EU advises not to approve lecanemab, a controversial drug for Alzheimer's.
  Media name/outlet	ABC (Spain)
  Media type	Web
  Country/Territory	Spain
  Date	26/07/24
  Persons	Tara Spires-Jones